DeviceTalks

In this episode of the DeviceTalks Weekly podcast, Kevin Chaplin, CEO of Kardium, a Vancouver-based electrophysiology device company, shares details of the company’s Globe® Pulsed Field Mapping and Ablation System. With $100 million in new capital, the company is poised to open a new front in the pulsed-field ablation battle. Thank you to Freudenberg Medical for sponsoring this episode. Go to Freudenbergmedical.com for more information. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode.

In the latest episode of DeviceTalks AI, President and CEO of Asensus Surgical, Anthony Fernando walks us through the significant differences between augmented intelligence and artificial intelligence and how Asensus is leveraging these technologies to improve surgical outcomes. Anthony discusses the inception and evolution of Asensus Surgical's innovative robotic platforms, including the Senhance and Luna systems, and delves into the core advantages of using augmented over artificial intelligence to aid surgeons. He describes the Intelligent Surgical Unit (ISU), its unique regulatory pathway, and its pivotal role in providing the surgeon with real-time context, ensuring higher precision, consistency, and reduced cognitive fatigue during surgeries. To get the full story on the Karl Storz acquisition of Asensus Surgical, visit: https://www.massdevice.com/asensus-to-be-acquired-karl-storz/ In the second part of the episode, GM of Health AI at Amazon Web Services (AWS), Tehsin Syed, talks about the intersection of healthcare, life sciences, and AI and how AWS is helping healthcare and life sciences organizations leverage AI without the need for extensive technical expertise. Tehsin highlights AWS services like Comprehend Medical and HealthScribe, which are designed to simplify the processing and analysis of healthcare data. He also discusses the potential of generative AI in accelerating drug discovery, clinical trial optimization, and personalized medicine. Make sure to check out DeviceTalks Spotlight, a growing library of insights and expertise from the best in the medical device business: https://gateway.on24.com/wcc/experience/elitewtwhmedia/2927718/4598161/devicetalks-spotlight Please subscribe to DeviceTalks AI on all major podcast channels and subscribe to DeviceTalks on YouTube to ensure you never miss an episode. Thank you for listening to DeviceTalks AI!

In this week’s DeviceTalks Weekly Podcast, we dig deeper into the worlds of Corporate Venture Capital and Surgical Robotics. In our keynote interviews, Host Tom Salemi speaks with Abby Hunter-Syed, director of Olympus Innovation Ventures (OIV), the corporate arm of Olympus, the medical giant. Hunter-Syed explains how her own entrepreneurial experience led her to discover the joy of supporting start-ups. In this interview she explains why she favors open communication and how entrepreneurs can best approach OIV for capital. Before that conversation, we visit with Surgical Robotics Expert Steve Bell, an MedTech veteran who now advised start-ups. We preview the upcoming annual meeting of the Society of Surgical Robotics, which promises to unveil many interesting new surgical robotics systems. You can find out more about Steve Bell at www.howtostartupinmedtech.com. This episode is sponsored by DeviceTalks West. Registration opens next week. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this episode of the DeviceTalks Weekly Podcast, Editorial Director Tom Salemi visits with Arun Menawat, CEO and Chairman of Profound Medical, developer of incision-free therapies which combine real-time MR imaging, thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue. In the conversation we’ll discuss Menawat’s past successes and his vision for the future of surgery. Go to profoundmedical.com for more information. Thank you to Profound Medical for sponsoring this episode of the DeviceTalks Weekly podcast. We’re also thrilled to announce the return of the Newmarker’s Newsmakers! Chris Newmarker returns with a wrap up of the hottest news on MassDevice.com, the medical device industry’s leading news source. This week we’ll cover news from Microbot Medical, Stryker, BD, Edwards and others. If you want to hear Joe Mullings take on the Karl Storz/Asensus deal go here. https://www.devicetalks.com/can-sovato-health-build-digital-highway-for-remote-robotic-surgery-unpacking-the-storz-asensus-news/ Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode.

In this episode of the DeviceTalks Weekly Podcast, we’ll talk with Gary Justak, president and general manager of Enovis’ foot & ankle business, about the rising war in the orthopedic extremities space. Co-hosts Tom Salemi and Chris Newmarker also host Jason Feipel, senior product development director of Medtronic’s Brain Modulation business, to find out details about the Percept RC DBS System. Andie Pequegnat, Director of Strategic Projects at Resonetics, teaches us more about nitinol. Resonetics sponsored this episode of the DeviceTalks Weekly Podcast and will host a DeviceTalks Tuesday discussion about nitinol later in June. Go to Resonetics.com for more information. Thank you for listening to the DeviceTalks Weekly Podcast. Don’t miss a episode by subscribing to the DeviceTalks Podcast Network.

In this episode of the DeviceTalks Weekly Podcast, we’ll replay our Day 2 opening keynote at DeviceTalks Boston with three senior leaders from CMR Surgical, creator of the versatile Versius surgical robotic systems. Co-Founder Mark Slack, MD, now CMO, and Luke Hares, now CTO, identified several problems facing the healthcare system and explained why they saw surgical robotics as the solution. Longtime Medical Device Leader Supratim Bose, now CEO of the company, lends his insights in how Versius can fill a huge need for healthcare systems and hospitals. This episode is sponsored by Qt Group. Listen to understand how they can help your medical device development or go to Qt.io for more information. Thank you for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network to listen to future episodes of this and our family of medical device podcasts. DeviceTalks.com

In this episode of DeviceTalks AI, we are joined by Ha Hong, PhD, Chief Artificial Intelligence Officer of Medtronic Endoscopy about integrating AI into Medtronic's endoscopy unit, the impact on healthcare outcomes, patient-centric design, and the future of AI in the medical device industry. Watch or listen to the episode to: - Discover how Ha's research coincided with the rise of deep learning, a pivotal technology in modern AI, and how it shaped his work in emulating visual perception processing in the brain. - Better understand Ha's instrumental role in developing the first FDA-approved AI-powered cardiac ultrasound guidance system, a groundbreaking innovation in cardiology. - Learn about Ha’s move to Medtronic and his vision for integrating AI into endoscopy, highlighting the potential for AI to revolutionize gastrointestinal diagnostics and treatment. - Gain insights into Ha's philosophy of patient-centric AI design, emphasizing the importance of prioritizing patient needs and safety in AI development for healthcare. In the episode, we also sit down with Joe Mish, VP of Sales at SmartTRAK to better understand how SmartTRAK is using AI to enhance their market intelligence solutions, combining the traditional robust analysis with advanced algorithms for more nuanced, speedier insights in the medtech industry. This conversation comes to you courtesy of our episode sponsor, SmartTRAK. To learn more about SmartTRAK, visit www.smarttrak.com. Please subscribe to DeviceTalks AI on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for listening to DeviceTalks AI!

In this episode of DeviceTalks Weekly, we visit with Elizabeth McCombs, executive vice president and chief technology officer at BD. This is a replay of the opening keynote interview at DeviceTalks Boston. This conversation comes to you courtesy of our sponsor – MTD Micro Molding. Go to MTDMicromolding.com for more information or scan the QR code. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network.

In this episode, the DeviceTalks Editorial Team - Tom Salemi, Kayleen Brown - recaps the highlights of DeviceTalks Boston with MassDevice Editor in Chief Chris Newmarker, Holly Scott of the Mullings Group, and Paul Melnychuck, Vice President & General Manager, Advanced Components at Spectrum Plastics Group, A DuPont Business. Spectrum Plastics Group sponsored the podcast. For more information go to SpectrumPlastics.com. Please subscribe to the DeviceTalks Podcast Network.

In this episode of AbbottTalks, Mahmood Kazemi, MD, Chief Medical Officer of Abbott’s Diabetes Care business overviews the profound advancements in diabetes management over the past decade and discusses the evolution of treatments and technological innovations that have revolutionized how individuals with diabetes approach their condition. Further, Dr. Kazemi underscores the benefits of advancements such as the GLP-1 receptor agonists and medications that control glucose levels and offer cardiovascular and renal protection. He then elaborates on how Abbott's FreeStyle Libre continuous glucose monitoring (CGM) systems have significantly improved diabetes management. These systems provide real-time data, empowering individuals to customize their medication, diet, and activity levels with unprecedented precision. He also speaks to Abbott's ongoing and future work, including developing a state-of-the-art continuous glucose ketone monitoring (CGKM) sensor. This medical biowearable is designed to provide crucial early warning signs in Type 1 diabetes management, a significant step towards preventing dangerous complications and hospitalizations. Looking to the future, Kazemi anticipates a wider adoption of CGM across the diabetes community, including those with type 2 diabetes, and an increase in insurer coverage. Thank you to BMP Medical for sponsoring this episode of AbbottTalks! For more information on how BMP Medical works with medical device companies, visit www.bmpmedical.com Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.